J&J Rebuffs Settlement Talks In Patent Dispute With Boston Scientific
A J&J spokesman declined to comment on the remarks, which were attributed to a spokesman for Boston Scientific, according to the newspaper.
The report comes amid amid ongoing trials in Delaware between the companies involving patents on their competing drug-coated cardiac stents used to treat clogged arteries.
Separately, a J&J spokesman told the newspaper he couldn't comment on...
To view the full article, register now.